Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · GoodRx Holdings, Inc. (GDRX)

GoodRx CFO Christopher McGinnis to step down; Justin Fengler named CFO effective Aug. 6

Neutral Impact 4 of 5 leadership Written later

GoodRx said CFO and Treasurer Christopher McGinnis will transition out of the role effective 11:59 p.m. Eastern on August 5, 2026, and that his departure is not due to any disagreement with the company. Chief Strategy & Operations Officer Justin Fengler will also become CFO & Treasurer and principal financial officer effective August 6, 2026, while continuing to oversee strategy and operations.

Key points

  • Christopher McGinnis leaves the CFO & Treasurer role effective 11:59 p.m. ET on August 5, 2026; the filing says the exit is not tied to any disagreement on operating performance, financial reporting or accounting.
  • Justin Fengler, 38, has been Chief Strategy & Operations Officer since September 2025 and with GoodRx since 2016; he takes over as CFO & Treasurer on August 6, 2026.
  • Fengler's compensation includes restricted stock units and performance stock units each valued at $600,000, plus a one-time $100,000 cash payment.
  • McGinnis expects to receive Tier I Executive Severance Plan benefits under a separation agreement the company has not yet signed.

The filing

CompanyGoodRx Holdings, Inc. (GDRX)
Form8-K, current report
Filed with the SECAug 5, 2026, 4:09 PM ET
Accession number0001809519-26-000153

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.